DK1011678T3 - Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser - Google Patents
Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelserInfo
- Publication number
- DK1011678T3 DK1011678T3 DK98939328T DK98939328T DK1011678T3 DK 1011678 T3 DK1011678 T3 DK 1011678T3 DK 98939328 T DK98939328 T DK 98939328T DK 98939328 T DK98939328 T DK 98939328T DK 1011678 T3 DK1011678 T3 DK 1011678T3
- Authority
- DK
- Denmark
- Prior art keywords
- mecamylamine
- nicotine
- treatment
- neuropsychiatric disorders
- responsive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5523497P | 1997-08-11 | 1997-08-11 | |
US93536497A | 1997-09-22 | 1997-09-22 | |
PCT/US1997/020689 WO1999007356A1 (en) | 1997-08-11 | 1997-11-07 | Nicotine antagonists for neuropsychiatric disorders |
PCT/US1998/016634 WO1999007378A1 (en) | 1997-08-11 | 1998-08-11 | Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1011678T3 true DK1011678T3 (da) | 2008-05-05 |
Family
ID=27368798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98939328T DK1011678T3 (da) | 1997-08-11 | 1998-08-11 | Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP4640888B2 (da) |
AU (1) | AU8778498A (da) |
CA (1) | CA2300148C (da) |
DK (1) | DK1011678T3 (da) |
ES (1) | ES2299214T3 (da) |
WO (1) | WO1999007378A1 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1367697A (zh) * | 1998-10-16 | 2002-09-04 | 詹森药业有限公司 | 改善认识的疗法 |
GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
JP2007516275A (ja) * | 2003-12-23 | 2007-06-21 | ファイザー・プロダクツ・インク | 認知増強および精神病性障害のための治療的組合せ |
WO2006101745A2 (en) * | 2005-03-18 | 2006-09-28 | Abbott Laboratories | Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions |
US11766429B1 (en) | 2020-08-26 | 2023-09-26 | University Of South Florida | Nicotinic receptor antagonists and pioglitazone as therapeutic agents for Covid-19 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5691365A (en) * | 1995-07-18 | 1997-11-25 | University Of Kentucky Research Foundation | Nicotinic receptor antagonists in the treatment of neuropharmacological disorders |
-
1998
- 1998-08-11 ES ES98939328T patent/ES2299214T3/es not_active Expired - Lifetime
- 1998-08-11 DK DK98939328T patent/DK1011678T3/da active
- 1998-08-11 WO PCT/US1998/016634 patent/WO1999007378A1/en active IP Right Grant
- 1998-08-11 CA CA002300148A patent/CA2300148C/en not_active Expired - Fee Related
- 1998-08-11 JP JP2000506968A patent/JP4640888B2/ja not_active Expired - Fee Related
- 1998-08-11 AU AU87784/98A patent/AU8778498A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2299214T3 (es) | 2008-05-16 |
JP4640888B2 (ja) | 2011-03-02 |
CA2300148A1 (en) | 1999-02-18 |
AU8778498A (en) | 1999-03-01 |
CA2300148C (en) | 2009-06-23 |
JP2003524573A (ja) | 2003-08-19 |
WO1999007378A1 (en) | 1999-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
DK1047428T3 (da) | Anvendelse af morpholinol til behandlingen af seksualforstyrrelser | |
IS5113A (is) | Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana | |
DK0830864T3 (da) | Kombinationsbehandling til behandling af psykoser | |
DK0812845T3 (da) | Fremgangsmåde til fremstilling af sildenafil | |
DK0941103T3 (da) | Farmaceutisk præparat til behandling af diabetes | |
DK1028954T3 (da) | Substituerede imidazoler egnede til behandling af inflammatoriske sygdomme | |
DK0861081T3 (da) | Anvendelse af epinastin til behandling af smerter | |
DK0752870T3 (da) | Anvendelse af Mycobacterium til behandling af tumorer | |
DE69807225T2 (de) | Vliesstoffbehandlung | |
DK1027315T3 (da) | Fremgangsmåde til fremstilling af n-butanol | |
DE59707096D1 (de) | Haarbehandlungsmittel zur Festigung der Haare | |
DK1053217T3 (da) | Fremgangsmåde til fremstilling af n-propanol | |
DK1028960T3 (da) | Fremgangsmåde til fremstilling af thiazolidinedion | |
IT1303677B1 (it) | Dispositivo per il trattamento termico di pezzi. | |
DK0928183T3 (da) | Anvendelse af 1-hydroxy-2-pyridoner til behandling af seborrhoisk dermatitis | |
DK0946514T3 (da) | Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler | |
DK1011678T3 (da) | Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser | |
DK0819113T3 (da) | Benzamider til behandling af neurodegenerative forstyrrelser | |
DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
DK0981349T3 (da) | 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme | |
DK1012152T3 (da) | Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer | |
PT1011678E (pt) | Utilização de mecamilamina para o tratamento de perturbações neuropsiquiátricas responsivas à nicotina. | |
DK0964681T3 (da) | Antikonvulsive derivater til behandling af psoriasis | |
ES1028213Y (es) | Ducha perfeccionada. |